Therapeutics
Search By Attributes
Search Results
| Name | Synonyms | FDA Status | Company | Target Type | Therapy Type | Condition | Approved For |
|---|---|---|---|---|---|---|---|
| AADvac-1 | Axon peptide 108 conjugated to KLH | 2 | Axon Neuroscience SE | Tau | Immunotherapy (active) | Alzheimer's Disease | |
| ABvac 40 | 2 | Araclon Biotech | Amyloid-Related | Immunotherapy (active) | Alzheimer's Disease | ||
| ACI-24 | Pal1-15 acetate salt | 1/2, 1 | AC Immune SA | Amyloid-Related | Immunotherapy (active) | Alzheimer's Disease, Down's Syndrome | |
| ACI-35 | 1 | AC Immune SA, Janssen | Tau | Immunotherapy (active) | Alzheimer's Disease | ||
| AN-1792 | AIP 001 | Discontinued | Janssen, Pfizer | Amyloid-Related | Immunotherapy (active) | Alzheimer's Disease | None |
| Affitope AD02 | 2 | AFFiRiS AG | Amyloid-Related | Immunotherapy (active) | Alzheimer's Disease | ||
| CAD106 | 2/3 | Novartis Pharmaceuticals Corporation | Amyloid-Related | Immunotherapy (active) | Alzheimer's Disease | None | |
| Lu AF20513 | 1 | H. Lundbeck, Otsuka Pharmaceutical Co., Ltd. | Amyloid-Related | Immunotherapy (active) | Alzheimer's Disease | ||
| UB 311 | 2 | United Neuroscience | Amyloid-Related | Immunotherapy (active) | Alzheimer's Disease | ||
| Vanutide cridificar | ACC-001, PF-05236806 |
Discontinued | Janssen | Amyloid-Related | Immunotherapy (active) | Alzheimer's Disease | None |